142 related articles for article (PubMed ID: 25962302)
1. [Postradial sialozoadenitis in patients with papillary carcinoma of the thyroid gland].
Kovalenko VA; Kopchak AV; Kovalenko AE
Vestn Khir Im I I Grek; 2015; 174(1):75-7. PubMed ID: 25962302
[TBL] [Abstract][Full Text] [Related]
2. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
6. Preserving formerly impaired salivary gland function in radioiodine-treated thyroid papillary carcinoma.
Aframian DJ; Nahlieli O; Knopf A; Lukach L; Qawasmeh N; Nadler C
Quintessence Int; 2013 May; 44(5):439-44. PubMed ID: 23479590
[TBL] [Abstract][Full Text] [Related]
7. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
Almeida JP; Sanabria AE; Lima EN; Kowalski LP
Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
[TBL] [Abstract][Full Text] [Related]
8. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
10. Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma.
Soo Roh S; Wook Kim D; Jin Baek H
AJR Am J Roentgenol; 2016 Nov; 207(5):1077-1081. PubMed ID: 27504709
[TBL] [Abstract][Full Text] [Related]
11. Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma.
Ish-Shalom S; Durleshter L; Segal E; Nagler RM
Eur J Endocrinol; 2008 May; 158(5):677-81. PubMed ID: 18426826
[TBL] [Abstract][Full Text] [Related]
12. Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin.
Rosario PW; Calsolari MR
Thyroid; 2013 May; 23(5):617-9. PubMed ID: 23136908
[TBL] [Abstract][Full Text] [Related]
13. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
[TBL] [Abstract][Full Text] [Related]
14. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
Kim DW
Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
[TBL] [Abstract][Full Text] [Related]
16. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
[No Abstract] [Full Text] [Related]
17. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa).
Gonzalez ME; Muttikkal TJ; Rehm PK
J Radiol Case Rep; 2015 Jun; 9(6):44-9. PubMed ID: 26622936
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
Patel SS; Goldfarb M
J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
[TBL] [Abstract][Full Text] [Related]
19. Iodide mumps: a case report of complicated radioactive iodine causing sialadenitis.
Lei L; Velasco O; Nobay F
Am J Emerg Med; 2012 Mar; 30(3):512.e5-6. PubMed ID: 21354757
[TBL] [Abstract][Full Text] [Related]
20. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.
Upadhyaya A; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Zhou P; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z
Medicine (Baltimore); 2017 Jun; 96(25):e7164. PubMed ID: 28640094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]